Author Correction: Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Janghee Lee, Chihwan Cha, Sung Gwe Ahn, Dooreh Kim, Soeun Park, Soong June Bae, Jeeye Kim, Hyung Seok Park, Seho Park, Seung Il Kim, Byeong‑Woo Park, Joon Jeong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd1f1338d654497baca5fe46e19e54b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Relationship of the standard uptake value of 18F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm
por: Soeun Park, et al.
Publicado: (2021) -
Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Ceren Boyaci, et al.
Publicado: (2021) -
KI67 AND P53 PROTEINS IN ODONTOGENIC KERATOCYST
por: S Seifi, et al.
Publicado: (2008) -
Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score
por: Soonmyung Paik, et al.
Publicado: (2021) -
Expression of Endothelin-1 and Ki-67 in Normotensive and Severe Preeclamptic Placentas
por: Ekinci,Aysun, et al.
Publicado: (2018)